Radiosensitization effects by bismuth oxide nanorods of different sizes in megavoltage external beam radiotherapy

Recent Breakthrough of Bismuth‐Based Nanostructured Materials for Multimodal Theranostic Applications

“…It was declared that genotoxicity aspects of bismuth with genomic DNA of tumor cells were rapidly higher than the nonexposed tumor cells' DNA; these results suggested that bismuth nanoparticles inhibit the growth of tumor cells in a dose-dependent manner [16]. In another recent report, [17] investigated the radiosensitization effect of bismuth oxide nanostructured rods by megavoltage radiotherapy treatment technology; and the authors also quantified the generation of sensitization enhancement ratio (SER) via photon and electron beams with respect to cancer cell death and further summarised that ultrasmall Bi 2 O 3 nanoparticulates regulate the efficient radiotherapy [16].…”

Analysis of Novel Schiff Base-Fe Complexes Against Breast Cancer Cells’ Viability

“…The current decade has shown the development of metallic nanoparticles (NPs) in medical fields, from in vitro testing to clinical trials, for various purposes such as antibacterial, anti-inflammation, anti-cancer, and radiosensitizer [1][2][3][4][5]. Among the significant metallic NPs being investigated for their varied applicability in medical fields are gold, platinum, bismuth, zinc, and iron NPs [6][7][8][9][10][11][12][13]. Due to their nanoscale sizes, the NPs are employed in the human body to produce their specific physical, chemical, and biological interactions with the surroundings [14][15][16][17].…”

“…Due to their nanoscale sizes, the NPs are employed in the human body to produce their specific physical, chemical, and biological interactions with the surroundings [14][15][16][17]. Besides, the metallic NPs' sizes and shapes could easily be customized and chemically synthesized based on their applications [12,[18][19][20][21][22].…”